Physician profile
James Osborn
NPI 1366417396
$8,967.49
in general payments reported to CMS, 2019-2025
9 companies · $1,908 in 2025
The $1,908 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $947 · 2021: $1,998 · 2022: $2,425 · 2023: $863 · 2025: $1,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1,908 · Consulting Fee: $800 · Food and Beverage: $62.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,907.94 |
| Consulting Fee | $800.00 |
| Food and Beverage | $62.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Camber Spine Technologies LLC | $3,745.45 | 2021-2023 | |
| The Institute of Musculoskeletal Science and Education | $3,107.94 | 2021-2025 | Spira |
| Spinal Elements, INC. | $719.20 | 2019-2020 | |
| Cerapedics INC. | $580.56 | 2020-2021 | |
| Nexxt Spine LLC | $418.98 | 2019-2021 | |
| Providence Medical Technology, INC. | $139.39 | 2020 | |
| Republic Spine | $137.42 | 2019 | |
| Innovation Technologies INC | $88.46 | 2021 | |
| Seaspine Orthopedics Corporation | $30.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Osborn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.